Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Jazz eyes a quick FDA nod for its $1B rare disease drug
Jazz eyes a quick FDA nod for its $1B rare disease drug
Jazz eyes a quick FDA nod for its $1B rare disease drug
Submitted by
admin
on September 30, 2015 - 4:49pm
Source:
Fierce Biotech
News Tags:
Jazz Pharmaceuticals
FDA
Defibrotide
hepatic veno-occlusive disease
Headline:
Jazz eyes a quick FDA nod for its $1B rare disease drug
Do Not Allow Advertisers to Use My Personal information